UPC (Universe Pharmaceuticals) Accumulated Depreciation: $-7.35 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UPC Universe Pharmaceuticals Inc UPC
59 GF Score
Price $5.54
GF Value $2.80
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Accumulated Depreciation?

Universe Pharmaceuticals UPC -10.90% 59 Accumulated Depreciation is $-7.35 Mil as of Mar. 2026. GuruFocus rates UPC with a GF Score™ of 59/100 and a GF Value™ of $2.80 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Universe Pharmaceuticals's quarterly accumulated depreciation increased from Mar. 2025 ($0.00 Mil) to Sep. 2025 ($-6.90 Mil) and increased from Sep. 2025 ($-6.90 Mil) to Mar. 2026 ($-7.35 Mil).

Universe Pharmaceuticals's annual accumulated depreciation increased from Sep. 2023 ($-6.05 Mil) to Sep. 2024 ($-6.67 Mil) and increased from Sep. 2024 ($-6.67 Mil) to Sep. 2025 ($-6.90 Mil).

Universe Pharmaceuticals Accumulated Depreciation Related Terms

Universe Pharmaceuticals Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Accumulated Depreciation Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Accumulated Depreciation
Get a 7-Day Free Trial -5.78 -5.71 -6.05 -6.67 -6.90

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.36 -6.67 0.00 -6.90 -7.35
UPC
59GF Score
Universe Pharmaceuticals Inc UPC
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universe Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-7.35 Mil mean?
Universe Pharmaceuticals (UPC) has a Accumulated Depreciation of $-7.35 Mil as of Mar. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Accumulated Depreciation too high?
Universe Pharmaceuticals' current Accumulated Depreciation is $-7.35 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Accumulated Depreciation compare to NPHC and CBIH?
Universe Pharmaceuticals' Accumulated Depreciation of $-7.35 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Accumulated Depreciation is $-7.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.80, compared to a current price of $5.54 — trading 97.9% above its estimated fair value. The current Accumulated Depreciation is $-7.35 Mil. Universe Pharmaceuticals' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Accumulated Depreciation is $-7.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be overvalued. The current stock price of $5.54 is trading 97.9% above its estimated GF Value™ of $2.80. GuruFocus considers Universe Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for UPC:

  • Accumulated Depreciation: $-7.35 Mil
  • GF Value™: $2.80 vs. price of $5.54 (97.9% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
59GF Score

Get the complete analysis for UPC

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.54
Price
$2.80
GF Value